Last reviewed · How we verify

NCT03898882: Peacocks

Pharmacokinetics of Oxytocin at Cesarean Delivery

Completed Last updated 7 May 2020
What this trial tests

trial testing oxytocin in Postpartum Hemorrhage in 30 participants. Completed in 28 February 2020.

Timeline
24 May 2019
Primary endpoint
28 February 2020
28 February 2020

Quick facts

Lead sponsorWashington University School of Medicine
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date24 May 2019
Primary completion28 February 2020
Estimated completion28 February 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Washington University School of Medicine

Who can join

Adults 18 to 45, female only, with Postpartum Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to obtain data to inform the design of a population pharmacokinetic study of oxytocin after administration at CD as per standard institutional practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of oxytocin

Trials testing the same drug.

Other recruiting trials for Postpartum Hemorrhage

Currently open trials in the same condition.

Other Washington University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03898882.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing